Metformin directly binds the alarmin HMGB1 and inhibits its proinflammatory activity

Metformin is the first-line drug in the treatment of type 2 diabetes. In addition to its hypoglycemic effect, metformin has an anti-inflammatory function, but the precise mechanism promoting this activity remains unclear. High mobility group box 1 (HMGB1) is an alarmin that is released from necrotic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Biol Chem
Main Authors: Horiuchi, Takahiro, Sakata, Natsumi, Narumi, Yoshihiro, Kimura, Tomohiro, Hayashi, Takashi, Nagano, Keisuke, Liu, Keyue, Nishibori, Masahiro, Tsukita, Sohei, Yamada, Tetsuya, Katagiri, Hideki, Shirakawa, Ryutaro, Horiuchi, Hisanori
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Biochemistry and Molecular Biology 2017
Assuntos:
Molecular Bases of Disease
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5437248/
https://ncbi.nlm.nih.gov/pubmed/28373282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M116.769380
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados